Pre-trial implementation study for ketamine in sickle cell disease

具体目标1：评估医疗保健利益攸关方对 亚麻下氯胺酮早期输注用于静脉镇痛的随机对照研究 使用实施研究综合框架(CFRIR)和Proctor的 实施成果的分类。为了实现这一目标，我们将：1A：进行横截面 EPPIC-Net内为艾滋病患者提供护理的医护人员的调查研究 SCD和/或为其医院系统内的氯胺酮给药提供指导(即， 专业包括血液学、急诊医学、麻醉学和住院医学) 评估拟议RCT 1B的障碍和促进者：实施半结构化 采访15-20名医疗保健专业人员，以评估计划的障碍和促进者 RCT。

Specific Aim 1: Assess healthcare stakeholders' perceptions of barriers to and facilitators for a RCT of early administration of sub-anesthetic ketamine infusion as a pain adjunct for VOEs using the Consolidated Framework for Implementation Research (CFRIR) and Proctor's taxonomy for implementation outcomes. To achieve this, we will: 1A: Conduct a cross-sectional survey study of healthcare professionals within EPPIC-Net who provide care for people with SCD and/or provide guidance for administration of ketamine within their hospital system (i.e., specialties including hematology, emergency medicine, anesthesiology, and hospitalist medicine) to assess barriers to and facilitators for the proposed RCT 1B: Conduct semi-structured interviews of 15-20 healthcare professionals to assess barriers to and facilitators for the proposed RCT.